INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
CD

Carr Douglas

SVP Finance & OperationsCIK 0001867173

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells0 / 9
Max Insider Score26
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$404
266 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Century Therapeutics, Inc.SVP Finance & Operations · Nov 5, 2025
19
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL
$3,200
1,658 sh
Sep 14, 2026
Sep 15, 2026
traded Sep 14, 2026
+1d
SEC FORM 4

Evidence

19
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$521
254 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

22
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$3,692
1,654 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC FORM 4

Evidence

22
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$526
249 sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC FORM 4

Evidence

17
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$618
264 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

17
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$589
323 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC FORM 4

Evidence

13
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Grant or award
A—
110.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

5
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Grant or award
A—
225.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

22
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$137
257 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

26
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$171
292 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence